- Home
- CCG vs IMMX Comparison
CCG vs IMMX Comparison
Compare CCG & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- IMMX
- Stock Information
- Founded
- CCG 2014
- IMMX 2014
- Country
- CCG China
- IMMX United States
- Employees
- CCG N/A
- IMMX N/A
- Industry
- CCG
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- CCG
- IMMX Health Care
- Exchange
- CCG Nasdaq
- IMMX Nasdaq
- Market Cap
- CCG 68.6M
- IMMX 61.1M
- IPO Year
- CCG N/A
- IMMX 2021
- Fundamental
- Price
- CCG $0.78
- IMMX $2.35
- Analyst Decision
- CCG Buy
- IMMX Strong Buy
- Analyst Count
- CCG 1
- IMMX 1
- Target Price
- CCG $350.00
- IMMX $7.00
- AVG Volume (30 Days)
- CCG 105.6K
- IMMX 540.4K
- Earning Date
- CCG 07-01-2025
- IMMX 08-11-2025
- Dividend Yield
- CCG N/A
- IMMX N/A
- EPS Growth
- CCG N/A
- IMMX N/A
- EPS
- CCG N/A
- IMMX N/A
- Revenue
- CCG $475,831,129.00
- IMMX N/A
- Revenue This Year
- CCG N/A
- IMMX N/A
- Revenue Next Year
- CCG $7.06
- IMMX N/A
- P/E Ratio
- CCG N/A
- IMMX N/A
- Revenue Growth
- CCG 5.20
- IMMX N/A
- 52 Week Low
- CCG $0.56
- IMMX $1.26
- 52 Week High
- CCG $1.54
- IMMX $3.00
- Technical
- Relative Strength Index (RSI)
- CCG 33.78
- IMMX 54.87
- Support Level
- CCG $0.74
- IMMX $2.20
- Resistance Level
- CCG $0.80
- IMMX $2.46
- Average True Range (ATR)
- CCG 0.04
- IMMX 0.27
- MACD
- CCG -0.00
- IMMX -0.01
- Stochastic Oscillator
- CCG 24.62
- IMMX 44.39
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.